This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe

Savings Deadline Expires In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
2-4 December 2024
Convention Centre DublinDublin, Ireland

Dr Hiro Usuda
Scouting & Transaction Lead, Business Development at Astellas Pharma Europe
Speaker

Profile

Hiro Usuda is Scouting & Transaction Lead, Business Development at Astellas. He moved to Cambridge, UK in 2021 when Astellas launched an BD office in Cambridge. He is responsible for introducing European technologies and assets to global Astellas, communicating with external partners, and creating new collaborations, licensing, M&A and investments (including in the field of Cell & Gene therapy). Hiro started his career at Astellas as a medicinal chemist, developing candidate drugs in immunology and oncology drug candidates as a bench chemist and group leader.

Agenda Sessions

  • Fuelling Funding: Securing the Future Innovation and Development of Advanced Therapies & Biologics in Ireland & Beyond

    16:15